Insider trades
Charles J. Homcy, Director of BridgeBio Pharma BBIO, has filed 0 purchases and 3 sales on the open market. The latest trade was on 06/22.
Charles J. Homcy
Director
- Company
- BridgeBio Pharma BBIO
- First filing
- 23/02/21
- Trades
- 46 trades
- Buys / sales
- 0 / 3
- 12-month net buying
- No record
- Last trade
- 06/22
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
BBIO | Open-market sale10b5-1 plan | 25/08/08–25/08/11 | 25/08/12 | 300,000 sh3 trades | $46.37avg. | $13,912,420.26 | −24.7% |